Clinical Trial: Predictive Role of KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of AIS
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Ischemic Stroke
Study Type: OBSERVATIONAL
Official Title: Predictive Role of Early Blood KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of Acute Ischemic Stroke
Brief Summary:
This study aims to investigate the dynamic changes and differential expression characteristics of neuroinflammatory molecules such as kallikrein-related peptidase 10 (KLK10), soluble triggering receptor expressed on myeloid cells 2 (sTREM2), and glial fibrillary acidic protein (GFAP) in the plasma of patients with first-ever anterior circulation acute ischemic stroke (AIS).It will analyze the correlation between these molecules and the severity of neurological deficits, infarct volume, brain edema, hemorrhagic…
Read more